469 related articles for article (PubMed ID: 25436583)
21. Epigenetic therapy of cancer with histone deacetylase inhibitors.
Lakshmaiah KC; Jacob LA; Aparna S; Lokanatha D; Saldanha SC
J Cancer Res Ther; 2014; 10(3):469-78. PubMed ID: 25313724
[TBL] [Abstract][Full Text] [Related]
22. Histone deacetylase inhibitors and their potential role in inflammatory bowel diseases.
Edwards AJ; Pender SL
Biochem Soc Trans; 2011 Aug; 39(4):1092-5. PubMed ID: 21787354
[TBL] [Abstract][Full Text] [Related]
23. Histone Deacetylase (HDAC) Inhibitors - emerging roles in neuronal memory, learning, synaptic plasticity and neural regeneration.
Ganai SA; Ramadoss M; Mahadevan V
Curr Neuropharmacol; 2016; 14(1):55-71. PubMed ID: 26487502
[TBL] [Abstract][Full Text] [Related]
24. The potential of HDAC inhibitors as cognitive enhancers.
Gräff J; Tsai LH
Annu Rev Pharmacol Toxicol; 2013; 53():311-30. PubMed ID: 23294310
[TBL] [Abstract][Full Text] [Related]
25. Tuning acetylation levels with HAT activators: therapeutic strategy in neurodegenerative diseases.
Selvi BR; Cassel JC; Kundu TK; Boutillier AL
Biochim Biophys Acta; 2010; 1799(10-12):840-53. PubMed ID: 20833281
[TBL] [Abstract][Full Text] [Related]
26. HDAC6 α-tubulin deacetylase: a potential therapeutic target in neurodegenerative diseases.
Li G; Jiang H; Chang M; Xie H; Hu L
J Neurol Sci; 2011 May; 304(1-2):1-8. PubMed ID: 21377170
[TBL] [Abstract][Full Text] [Related]
27. [Histone deacetylase inhibitors as therapeutic agents for polyglutamine disorders].
Jiang H; Jia D; Tang B
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Feb; 27(1):52-5. PubMed ID: 20140868
[TBL] [Abstract][Full Text] [Related]
28. Linking epigenetics to lipid metabolism: focus on histone deacetylases.
Ferrari A; Fiorino E; Giudici M; Gilardi F; Galmozzi A; Mitro N; Cermenati G; Godio C; Caruso D; De Fabiani E; Crestani M
Mol Membr Biol; 2012 Nov; 29(7):257-66. PubMed ID: 23095054
[TBL] [Abstract][Full Text] [Related]
29. KATching-Up on Small Molecule Modulators of Lysine Acetyltransferases.
Simon RP; Robaa D; Alhalabi Z; Sippl W; Jung M
J Med Chem; 2016 Feb; 59(4):1249-70. PubMed ID: 26701186
[TBL] [Abstract][Full Text] [Related]
30. Histone deacetylases as targets for the treatment of human neurodegenerative diseases.
D'Mello SR
Drug News Perspect; 2009 Nov; 22(9):513-24. PubMed ID: 20072728
[TBL] [Abstract][Full Text] [Related]
31. Histone deacetylase function in CD4
Ellmeier W; Seiser C
Nat Rev Immunol; 2018 Oct; 18(10):617-634. PubMed ID: 30022149
[TBL] [Abstract][Full Text] [Related]
32. Histone deacetylase inhibitors and neurodegenerative disorders: holding the promise.
Mai A; Rotili D; Valente S; Kazantsev AG
Curr Pharm Des; 2009; 15(34):3940-57. PubMed ID: 19751207
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of histone acetylation and deacetylation enzymes affects longevity, development, and fecundity in the pea aphid (Acyrthosiphon pisum).
Kirfel P; Skaljac M; Grotmann J; Kessel T; Seip M; Michaelis K; Vilcinskas A
Arch Insect Biochem Physiol; 2020 Mar; 103(3):e21614. PubMed ID: 31498475
[TBL] [Abstract][Full Text] [Related]
34. Epigenetic treatment of neurological disease.
Gray SG
Epigenomics; 2011 Aug; 3(4):431-50. PubMed ID: 22126204
[TBL] [Abstract][Full Text] [Related]
35. Histones and lung cancer: Are the histone deacetylases a promising therapeutic target?
Petta V; Gkiozos I; Strimpakos A; Syrigos K
Cancer Chemother Pharmacol; 2013 Nov; 72(5):935-52. PubMed ID: 24036844
[TBL] [Abstract][Full Text] [Related]
36. Role of histone acetyltransferases and histone deacetylases in adipocyte differentiation and adipogenesis.
Zhou Y; Peng J; Jiang S
Eur J Cell Biol; 2014 Apr; 93(4):170-7. PubMed ID: 24810880
[TBL] [Abstract][Full Text] [Related]
37. Targeting histone acetylation for neuroprotection.
Contestabile A
Curr Pharm Des; 2013; 19(28):5017-8. PubMed ID: 23448467
[No Abstract] [Full Text] [Related]
38. Differential regulation of Bdnf expression in cortical neurons by class-selective histone deacetylase inhibitors.
Koppel I; Timmusk T
Neuropharmacology; 2013 Dec; 75():106-15. PubMed ID: 23916482
[TBL] [Abstract][Full Text] [Related]
39. Multiple roles of HDAC inhibition in neurodegenerative conditions.
Chuang DM; Leng Y; Marinova Z; Kim HJ; Chiu CT
Trends Neurosci; 2009 Nov; 32(11):591-601. PubMed ID: 19775759
[TBL] [Abstract][Full Text] [Related]
40. Effects of exercise and pharmacological inhibition of histone deacetylases (HDACs) on epigenetic regulations and gene expressions crucial for neuronal plasticity in the motor cortex.
Maejima H; Kitahara M; Takamatsu Y; Mani H; Inoue T
Brain Res; 2021 Jan; 1751():147191. PubMed ID: 33152341
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
